These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9145179)

  • 1. An analysis of the outcomes of treatment of small cell lung cancer in the elderly.
    Tebbutt NC; Snyder RD; Burns WI
    Aust N Z J Med; 1997 Apr; 27(2):160-4. PubMed ID: 9145179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients.
    Koumarianou A; Fountzilas G; Kosmidis P; Klouvas G; Samantas E; Kalofonos C; Pentheroudakis G; Economopoulos T; Pectasides D
    J Chemother; 2009 Nov; 21(5):573-83. PubMed ID: 19933050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiotherapy for limited-disease small-cell lung cancer in elderly patients aged 75 years or older.
    Shukuya T; Takahashi T; Harada H; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi K; Yamamoto N
    Jpn J Clin Oncol; 2013 Feb; 43(2):176-83. PubMed ID: 23225910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in elderly patients with nonsmall cell lung cancer.
    Veluswamy RR; Levy B; Wisnivesky JP
    Curr Opin Pulm Med; 2016 Jul; 22(4):336-43. PubMed ID: 27100301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.
    Schild SE; Stella PJ; Geyer SM; Bonner JA; McGinnis WL; Mailliard JA; Brindle J; Jatoi A; Jett JR;
    J Clin Oncol; 2003 Sep; 21(17):3201-6. PubMed ID: 12874270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of small cell lung carcinoma in the elderly.
    Dajczman E; Fu LY; Small D; Wolkove N; Kreisman H
    Cancer; 1996 May; 77(10):2032-8. PubMed ID: 8640666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of small cell lung cancer in the elderly based on a critical literature review of clinical trials.
    Sekine I; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N
    Cancer Treat Rev; 2004 Jun; 30(4):359-68. PubMed ID: 15145510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma.
    Yuen AR; Zou G; Turrisi AT; Sause W; Komaki R; Wagner H; Aisner SC; Livingston RB; Blum R; Johnson DH
    Cancer; 2000 Nov; 89(9):1953-60. PubMed ID: 11064352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.
    Tseng YH; Tseng YC; Lin YH; Lee YC; Perng RP; Whang-Peng J; Chen YM
    Oncologist; 2015 Jul; 20(7):758-66. PubMed ID: 26054633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
    Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J; Chen P; Dai CH; Li XQ; Bao QL
    Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy.
    Crvenkova S; Pesevska M
    J BUON; 2015; 20(3):775-81. PubMed ID: 26214630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.
    Kubo T; Fujiwara K; Hotta K; Okada T; Kuyama S; Harita S; Ninomiya T; Kamei H; Hosokawa S; Bessho A; Maeda T; Kozuki T; Fujimoto N; Ninomiya K; Takemoto M; Kanazawa S; Takigawa N; Tabata M; Tanimoto M; Ueoka H; Kiura K
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):769-74. PubMed ID: 27544764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefit of chemotherapy in elderly patients with small cell lung cancer.
    Caprario LC; Strauss GM
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):645-7. PubMed ID: 24655123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.
    Jatoi A; Hillman S; Stella P; Green E; Adjei A; Nair S; Perez E; Amin B; Schild SE; Castillo R; Jett JR;
    J Clin Oncol; 2005 Dec; 23(36):9113-9. PubMed ID: 16361618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of elderly patients with advanced non-small cell lung cancer: a single-center experience.
    Früh M; Besrour H; Gillessen S; Joerger M; Hitz F; Savidan A; Cerny T; Ess S
    Chemotherapy; 2013; 59(1):42-50. PubMed ID: 23838903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer after 70: is it a different disease?
    Lebovic DJ; Mahmood T; Chiappori A
    Oncology (Williston Park); 2010 Nov; 24(12):1106-11, 1114. PubMed ID: 21141691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.
    Coate LE; Massey C; Hope A; Sacher A; Barrett K; Pierre A; Leighl N; Brade A; de Perrot M; Waddell T; Liu G; Feld R; Burkes R; Cho BC; Darling G; Sun A; Keshavjee S; Bezjak A; Shepherd FA
    J Thorac Oncol; 2011 Mar; 6(3):537-44. PubMed ID: 21258243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.